Defining the Breakpoints to Fill the Gap: The Evolving Role of Chromosomal Microarray with Catherine Schultz, MS, CGC

• Chromosomal microarray (CMA) has been a powerful tool for the evaluation and diagnosis of individuals with intellectual disability, global developmental delay, autism spectrum disorder, and/or multiple congenital anomalies for over a decade. In that time, rapid advances have been made impacting the detection of copy number variants (CNV) through arrayCGH (aCGH) and next-generation sequencing (NGS) technologies. Despite the rapid development in technology and analysis of the human genome, many challenges of CNV detection, classification and clinical interpretation remain and continue to be uncovered. Join this webinar as we explore the history of CMA, current challenges and the impact of whole exome and genomes sequencing on its use in clinical practice.

  Level of Instruction: Basic

  

  Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.

  

  Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.

Catherine Schultz, MS, CGC | Presenter

Sr. Medical Science Liaison-Medical Genetics & Reproductive Health, Ambry Genetics

Catherine received her MS in Genetic Counseling from the University of Alabama at Birmingham and practiced clinically as a multidisciplinary genetic counselor in Birmingham, AL prior to joining Ambry 7 years ago. As a Genomic Science Liaison for the Southcentral United States, she served as a clinical liaison for the field team to educate health care providers on genetic testing and genomic medicine. In her current role as a Medical Science Liaison, Catherine engages key opinion leaders and members of the medical and scientific community to advance the development of novel testing approaches and improve the utility of existing clinical tests.

Margo Gallegos, MS, LCGC | Moderator

Genomic Science Liaison II, Cardio/Rare Disease, Ambry Genetics

Margo Gallegos joined Ambry Genetics in 2020 as the Specialty Genomic Science Liaison for the Northeast United States territory. She previously worked as a pediatric genetic counselor at Children’s National Medical Center in Washington, D.C, and an oncology genetic counselor at Anne Arundel Medical Center in Annapolis, MD. Her volunteer interests include public policy and licensure of genetic counselors both at the state and federal level. Margo received her Bachelors of Science degree in Cell Biology and Genetics from University of Maryland, College Park. She earned her Masters of Science degree in Genetic Counseling from University of South Carolina School of Medicine and is certified by the American Board of Genetic Counseling.